risperidone trials for Schizophrenia

All risperidone trials · All Schizophrenia trials

Phase breakdown

Recruiting trials studying risperidone for Schizophrenia

• "Extended" (Alternate Day) Antipsychotic Dosing
  NCT04478838 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Biomarkers to Enhance Early Schizophrenia Treatment
  NCT06969755 · Phase: Phase 4 · Ages: 18 Years to 35 Years · Sex: All (male and female) · 5 locations
• CLOZAPINE Response in Biotype-1
  NCT04580134 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 5 locations
• Cerebellum-based Imaging Neural Markers for Antipsychotic Response
  NCT07483294 · Phase: Phase 4 · Ages: 15 Years to 40 Years · Sex: All (male and female) · 1 location
• Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
  NCT07565428 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 13 locations

Common questions

How many trials study risperidone for Schizophrenia?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.